Clinical Trials on Non-Small Cell Lung Cancer ALK-positive in United Kingdom
Total 10948 results
-
European Organisation for Research and Treatment...Active, not recruitingEGFR Mutation Positive Non Small Cell Lung CancerUnited Kingdom
-
University Hospital Southampton NHS Foundation...Royal Bournemouth and Christchurch Hospitals NHS Foundation TrustUnknownNon Small Cell Lung Cancer | Non Small Cell Lung Cancer Stage IIIB | Non Small Cell Lung Cancer MetastaticUnited Kingdom
-
Massachusetts General HospitalAmerican Lung AssociationRecruitingCarcinoma, Non-Small-Cell Lung | Nonsmall Cell Lung Cancer | Palliative Care | Survivorship | Targeted Therapy | Stage IV Non-small Cell Lung Cancer | EGFR Positive Non-small Cell Lung Cancer | ALK-positive Non-small Cell Lung CancerUnited States
-
Royal Marsden NHS Foundation TrustBristol-Myers SquibbActive, not recruitingNon-small Cell Lung Cancer Stage I | Non-small Cell Lung Cancer Stage IIUnited Kingdom
-
Boehringer IngelheimCompletedNon-squamous, Non-Small Cell Lung CancerUnited Kingdom
-
QIAGEN Gaithersburg, IncAmgenActive, not recruitingNon Small Cell Lung CancerUnited Kingdom
-
QIAGEN Gaithersburg, IncAmgenActive, not recruitingNon-small Cell Lung CancerUnited Kingdom
-
AstraZenecaCompletedNon-small-cell Lung CancerUnited Kingdom
-
University of HullHull University Teaching Hospitals NHS TrustWithdrawnLung Cancer | Non-small Cell Lung CancerUnited Kingdom
-
Oxford University Hospitals NHS TrustNational Institute for Health Research, United KingdomCompleted
-
Royal Marsden NHS Foundation TrustUnknownNon-small Cell Lung CancerUnited Kingdom
-
Mayo ClinicNational Cancer Institute (NCI)TerminatedStage IV Non-Small Cell Lung Cancer AJCC v7 | Stage IIIA Non-Small Cell Lung Cancer AJCC v7 | Stage III Non-Small Cell Lung Cancer AJCC v7 | Stage IIIB Non-Small Cell Lung Cancer AJCC v7 | Mesothelin PositiveUnited States
-
Institute of Cancer Research, United KingdomMerck Sharp & Dohme LLC; Merck Serono GmbH, GermanyRecruitingNon Small Cell Lung Cancer | Advanced CancerUnited Kingdom
-
The Christie NHS Foundation TrustAstraZeneca; University of ManchesterCompleted
-
University College, LondonCancer Research UKRecruitingSmall Cell Lung Cancer | Lung Cancer, Non-small Cell | Pleural MesotheliomaUnited Kingdom
-
Cancer Research UKCompletedAdvanced Non-small Cell Lung CancerUnited Kingdom
-
Liverpool Heart and Chest Hospital NHS Foundation...WithdrawnNon Small Cell Lung Cancer | Aspirin | SurvivalUnited Kingdom
-
Royal Marsden NHS Foundation TrustMerck Sharp & Dohme LLCTerminatedMetastatic Non-small-cell lunG CancerUnited Kingdom
-
Dana-Farber Cancer InstituteGenentech, Inc.TerminatedALK-positive Non-small Cell Lung Cancer (NSCLC) | RET-positive Non-small Cell Lung Cancer (NSCLC) | RET-positive Thyroid CancerUnited States
-
PfizerNo longer availableNon Small Cell Lung Cancer ALK Positive or ROS1 PositiveUnited States
-
Achilles Therapeutics UK LimitedTerminatedMelanoma | Advanced Non Small Cell Lung CancerUnited Kingdom
-
Agenus Inc.CompletedLung Cancer | Non-Small-Cell Lung Carcinoma | Pulmonary CancerUnited Kingdom
-
Hoffmann-La RocheCompletedNon-Squamous Non-Small Cell Lung CancerNetherlands, United Kingdom
-
Cancer Research UKAstraZenecaCompletedCancer | Non Small Cell Lung CancerUnited Kingdom
-
University of Wisconsin, MadisonNational Cancer Institute (NCI)CompletedStage IIIA Non-small Cell Lung Cancer | Stage IIIB Non-small Cell Lung Cancer | Extensive Stage Small Cell Lung Cancer | Recurrent Small Cell Lung Cancer | Recurrent Non-small Cell Lung Cancer | Stage IV Non-small Cell Lung Cancer | Healthy, no Evidence of Disease | Limited Stage Small Cell Lung... and other conditionsUnited States
-
European Organisation for Research and Treatment...UnknownNon-small Cell Lung Cancer Stage I | Non-small Cell Lung Cancer Stage IIGermany, Belgium, United Kingdom, Switzerland
-
Eli Lilly and CompanyCompletedNon-Small Cell Lung Cancer Metastatic | Nonsquamous Non-Small Cell Neoplasm of Lung | Non-Small Cell Lung Cancer Stage IIIBUnited Kingdom, Sweden
-
Lisette NixonCompletedLocally Advanced Non-small Cell Lung CancerUnited Kingdom
-
PfizerCompletedALK-positive Non Small Cell Lung Cancer (NSCLC) and ROS1-positive NSCLCUnited States, Canada, Australia, Taiwan, Singapore, Japan, Korea, Republic of, Spain, Belgium, Switzerland, France, Germany, Hong Kong, Italy
-
BIND TherapeuticsCompletedSquamous Cell Non-small Cell Lung Cancer | KRAS Positive Patients With Non-small Cell Lung CancerUnited States, Russian Federation
-
Prof Corinne Faivre-FinnRoyal Marsden NHS Foundation Trust; The Leeds Teaching Hospitals NHS Trust; Cambridge... and other collaboratorsCompletedNon Small Cell Lung CancerUnited Kingdom
-
Cancer Research UKBicycle TherapeuticsCompletedNon-Small Cell Lung Cancer | Advanced Solid Tumours | Oesophageal Cancer | Non-Small Cell Lung SarcomaUnited Kingdom
-
University College, LondonHoffmann-La RocheActive, not recruitingNon-small Cell Lung CancerUnited Kingdom
-
University of OxfordCancer Research UK; Guy's and St Thomas' NHS Foundation Trust; NHS Lothian; National... and other collaboratorsCompletedLocally Advanced Non-Small Cell Lung CancerUnited Kingdom
-
GlaxoSmithKlineCompletedLung Cancer, Non-Small CellUnited States, United Kingdom
-
Clovis Oncology, Inc.TerminatedLung Cancer | Solid Tumor | Non-small-cell Lung CancerUnited States, United Kingdom
-
BayerRecruitingHealthy Volunteers | Advanced Non-small Cell Lung Cancer | EGFR Mutation | HER2 MutationUnited Kingdom
-
AbbVieRecruitingNon Small Cell Lung CancerCanada, United Kingdom
-
Novartis PharmaceuticalsCompletedALK-positive Non-small Cell Lung CancerUnited States, France, Italy, United Kingdom, Taiwan, Turkey, Belgium, Germany, Canada, Singapore, Spain, Korea, Republic of, Netherlands, Russian Federation, Brazil, Hong Kong, Australia
-
Debiopharm International SASyneos HealthTerminatedNon-small Cell Lung CancerSpain, France, United Kingdom
-
University of California, San FranciscoAstraZenecaActive, not recruitingStage IIIA Non-Small Cell Lung Cancer | Stage I Non-Small Cell Lung Cancer | Stage IA Non-Small Cell Lung Cancer | Stage IB Non-Small Cell Lung Cancer | Stage II Non-Small Cell Lung Cancer | Stage IIA Non-Small Cell Lung Cancer | Stage IIB Non-Small Cell Lung CancerUnited States
-
National Cancer Institute (NCI)TerminatedStage IIIA Non-small Cell Lung Cancer | Stage IA Non-small Cell Lung Cancer | Stage IB Non-small Cell Lung Cancer | Stage IIA Non-small Cell Lung Cancer | Stage IIB Non-small Cell Lung CancerUnited States
-
AstraZenecaCompletedNon-Small Cell Lung Cancer NSCLCUnited Kingdom
-
WindMIL TherapeuticsBristol-Myers SquibbTerminatedNSCLC | Lung Cancer | Lung Cancer Metastatic | Lung Cancer, Non-small Cell | Non Small Cell Lung Cancer | Non-small Cell Lung Cancer | Non-small Cell Lung Cancer Metastatic | Non Small Cell Lung Cancer MetastaticUnited States
-
University College, LondonBoehringer IngelheimCompletedNon-small Cell Lung CancerUnited Kingdom
-
University of LeedsUniversity College London Hospitals; The Leeds Teaching Hospitals NHS Trust; University... and other collaboratorsRecruitingNon Small Cell Lung CancerUnited Kingdom
-
GenmabTerminatedNon Small Cell Lung CancerBelgium, United States, France, Netherlands, United Kingdom
-
Stanford UniversityAstraZenecaRecruitingNon-small Cell Lung Cancer Stage III | Non-small Cell Lung Cancer | Non-small Cell Lung Cancer Stage I | Non-small Cell Lung Cancer Stage IIUnited States
-
Ohio State University Comprehensive Cancer CenterActive, not recruitingStage IIIA Non-small Cell Lung Cancer | Stage IIIB Non-small Cell Lung Cancer | Recurrent Non-small Cell Lung Cancer | Stage IIA Non-small Cell Lung Cancer | Stage IIB Non-small Cell Lung CancerUnited States
-
AstraZenecaCompletedAdvanced Non Small Cell Lung Cancer | Advanced (Inoperable) Non Small Cell Lung CancerFrance, Korea, Republic of, United Kingdom, Spain